Skip to main content

and
  1. No Access

    Article

    Pancreatic NETs: where do we stand now?

    The systemic management of patients with pancreatic neuroendocrine tumors includes chemotherapy and targeted agents such as everolimus and sunitinib. Which treatment to favor in a particular patient is not kno...

    S. Faivre, D. Castellano, J. Strosberg, E. González in Cancer and Metastasis Reviews (2014)